U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C11H12ClNO4
Molecular Weight 257.67
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SALCLOBUZIC ACID

SMILES

OC(=O)CCCNC(=O)C1=CC=C(Cl)C=C1O

InChI

InChIKey=GCVGCXMTCJMBHY-UHFFFAOYSA-N
InChI=1S/C11H12ClNO4/c12-7-3-4-8(9(14)6-7)11(17)13-5-1-2-10(15)16/h3-4,6,14H,1-2,5H2,(H,13,17)(H,15,16)

HIDE SMILES / InChI

Description

Salclobuzate sodium was developed as an oral absorption promoter. This compound had to “chaperone” poorly permeable payloads across the intestine. Information about the current use of this compound is not available.

Approval Year

Unknown
149,124

PubMed

Patents

07208178
2
07227033
2
07351741
2
07420085
2
07462368
2
07893297
2
SALT/SOLVATE (PARENT)
Structure of SALCLOBUZATE SODIUM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966